califesciences052222
Catalent Pharma Solutions' main campus is pictured March 2021. Catalent announced they are investing $350 million in a manufacturing facility in Bloomington in order to increase its pharmaceutical manufacturing abilities.
Catalent Pharma Solutions' main campus is pictured March 2021. Catalent announced they are investing $350 million in a manufacturing facility in Bloomington in order to increase its pharmaceutical manufacturing abilities. IDS file photo
Catalent Pharma Solutions' main campus is pictured March 2021. Catalent announced they are investing $350 million in a manufacturing facility in Bloomington in order to increase its pharmaceutical manufacturing abilities.